DoW Rare Cancers Idea Development Award

About this funding opportunity

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.

Distinctive Features:

The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.

Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.

Research should have high potential impact on rare cancers and the patient community.

Topic areas: General and Cross-cutting R&D, Life Sciences and Health.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are due Nov 18, 2026. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• Open to all applicant types

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

DoW Rare Cancers Idea Development Award is administered by Defense Health Agency Contracting Activity - DHACA (AMRAA), listed via Grants.gov.